References

1. Richardson, P.; McKenna, W.; Bristow, M.; Maish, B.; Mautner, B.; O'Connell, J.; Olsen, E.; Thiene, G.; Goodwin, J.; Gyarfas, I.; Martin, I.; Nordet, P. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996, 93, 841-842.

2. Klues, H.G.; Schiffers, A.; Maron, B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocar-diography in 600 patients. J. Am. Coll. Cardiol. 1995, 26, 1699-1708.

3. Maron, B.J.; Casey, S.A.; Hauser, R.G.; Aeppli, D.M. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J. Am. Coll. Cardiol. 2003, 42, 882-888.

4. Kuhn, H.; Mercier, J.; Kohler, E.; Frenzel, H.; Hort, W.; Loogen, F. Differential diagnosis of hypertrophic cardiomyopathies: Typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy. Eur. Heart J. 1983, 4 (Suppl. F), 93104.

5. Maron, B.J.; McKenna, W.J.; Danielson, G.K.; Kappen-berger, L.J.; Kuhn, H.J.; Seidman, C.E.; Shah, P.M.; Spencer, W.H.; Spirito, P.; Ten Cate, F.J.; Wigle, E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hyper-trophic cardiomyopathy. Eur. Heart J. 1999, 24, 1965 -1991.

6. Maron, B.J.; Olivotto, I.; Spirito, P.; Casey, S.A.; Bellone, P.; Gohman, T.E.; Graham, K.J.; Burton, D.A.; Cecchi, F. Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. Circulation 2000, 102, 858 - 864.

7. Bonne, G.; Carrier, L.; Richard, P.; Hainque, B.; Schwartz, K. Familial hypertrophic cardiomyopathy: From mutations to functional defects. Circ. Res. 1998, 83, 580593.

8. Minamisawa, S.; Sato, Y.; Tatsuguchi, Y.; Fujino, T.; Imamura, S.; Uetsuka, Y.; Nakazawa, M.; Matsuoka, R. Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 2003, 304, 1-4.

9. Richard, P.; Charron, P.; Carrier, L.; Ledeuil, C.; Cheav, T.; Pichereau, C.; Benaiche, A.; Isnard, R.; Dubourg, O.; Burban, M.; Gueffet, J.P.; Millaire, A.; Desnos, M.; Schwartz, K.; Hainque, B.; Komajda, M. Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations and implications for molecular diagnosis strategy. Circulation 2003, 107, 2227-2232.

10. Fatkin, D.; Graham, R.M. Molecular mechanisms of inherited cardiomyopathies. Physiol. Rev. 2002, 82, 945-980.

11. Cuda, G.; Fananapazir, L.; Zhu, W.S.; Seller, J.R.; Epstein, N.E. Skeletal muscle expression and abnormal function of b-myosin in hypertrophic cardiomyopathy. J. Clin. Invest. 1993, 91, 2861-2865.

12. Bottinelli, R.; Coviello, D.A.; Redwood, C.S.; Pellegrino, M.A.; Maron, B.J.; Spirito, P.; Watkins, H.; Reggiani, C. A mutant tropomyosin that causes hypertrophic cardio-myopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ. Res. 1998, 82, 106-115.

13. Flavigny, J.; Souchet, M.; Sebillon, P.; Berrebi-Bertrand, I.; Hainque, B.; Mallet, A.; Bril, A.; Schwartz, K.; Carrier, L. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/

or incorporation in fetal rat cardiomyocytes. J. Mol. Biol. 1999, 294, 443-456.

14. Sarikas, A.; Schenke, C.; Carrier, L.; Eschenhagen, T.; Zolk, O. Mutated cardiac myosin binding protein C is degraded by the proteasome. ESC Congress 2003 (Vienna, Austria). Eur. Heart J. 2003, 24, 589.

15. Rottbauer, W.; Gautel, M.; Zehelein, J.; Labeit, S.; Franz, W.M.; Fischer, C.; Vollrath, B.; Mall, G.; Dietz, R.; Kubler, W.; Katus, H.A. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J. Clin. Invest. 1997, 100, 475-482.

16. Moolman, J.A.; Reith, S.; Uhl, K.; Bailey, S.; Gautel, M.; Jeschke, B.; Fisher, C.; Ochs, J.; McKenna, W.J.; Klues,

H.; Vosberg, H.P. A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation 2000, 101, 1396-1402.

17. Vignier, N.; Perrot, A.; Schulte, H.D.; Richard, P.; Sebillon, P.; Schwartz, K.; Osterziel, K.; Carrier, L. Cardiac myosin-binding protein C and familial hypertro-phic cardiomyopathy: From mutations identification to human endomyocardial proteins analysis. 74th Scientific Sessions of the American Heart Association (Anaheim, CA). Circulation 2001, 104, II-1. Supplement.

18. Carrier, L.; Knoll, R.; Vignier, N.; Keller, D.I.; Bausero, P.; Prudhon, B.; Isnard, R.; Ambroisine, M.L.; Fiszman, M.; Ross, J.; Schwartz, K.; Chien, K.R. Asymmetric sep-tal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc. Res. 2004, in press.

19. Ashrafian, H.; Redwood, C.; Blair, E.; Watkins, H. Hypertrophic cardiomyopathy: A paradigm for myocar-dial energy depletion. Trends Genet. 2003, 19, 263 -268.

20. Schwartz, K.; Mercadier, J.J. Cardiac troponin T and familial hypertrophic cardiomyopathy: An energetic affair. J. Clin. Invest. 2003, 112, 652-654.

21. Crilley, J.G.; Boehm, E.A.; Blair, E.; Rajagopalan, B.; Blamire, A.M.; Styles, P.; McKenna, W.J.; Ostman-Smith,

I.; Clarke, K.; Watkins, H. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment